|
G |
Bax |
BCL2-associated X protein |
multiple interactions increases expression |
ISO |
[[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP3 protein; [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP9 protein; [[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein |
CTD |
PMID:20638373 |
|
NCBI chr 7:45,461,695...45,466,903
Ensembl chr 7:45,461,697...45,466,898
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
decreases expression multiple interactions |
ISO |
cajanol results in decreased expression of BCL2 protein [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP3 protein; [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP9 protein; [[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein |
CTD |
PMID:20638373 |
|
NCBI chr 1:106,538,176...106,714,290
Ensembl chr 1:106,538,178...106,714,274
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
[[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP3 protein cajanol results in increased activity of CASP3 protein |
CTD |
PMID:20638373 |
|
NCBI chr 8:46,617,291...46,639,698
Ensembl chr 8:46,617,291...46,639,689
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity |
ISO |
[[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP9 protein cajanol results in increased activity of CASP9 protein |
CTD |
PMID:20638373 |
|
NCBI chr 4:141,793,612...141,815,978
Ensembl chr 4:141,793,612...141,815,976
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization multiple interactions |
ISO |
cajanol affects the localization of CYCS protein [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP3 protein; [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP9 protein; [[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein |
CTD |
PMID:20638373 |
|
NCBI chr 6:50,562,563...50,566,569
Ensembl chr 6:50,562,563...50,566,538
|
|